Lv2
134 积分 2026-02-26 加入
Liver-Directed Gene Therapy: A Retroviral Vector with a Complete LTR and the ApoE Enhancer- α 1 -Antitrypsin Promoter Dramatically Increases Expression of Human α 1 -Antitrypsin In Vivo
2天前
已完结
Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers
2天前
已完结
Co‐Delivery of Multiple RNAs via Lipid Nanoparticles Enables Precise Gene Editing of CAR‐T Cells
4天前
已完结
Sequential reading of a stepwise-shortened peptide immobilized on nanopore
10天前
已完结
Comparative transport analysis of cell penetrating peptides and Lysosomal sequences for selective tropism towards RPE cells
12天前
已完结
CD44 aptamer mediated cargo delivery to lysosomes of retinal pigment epithelial cells to prevent age-related macular degeneration
12天前
已完结
Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates
12天前
已完结
Abstract CT021: Preliminary safety and clinical activity of zoldonrasib (RMC-9805), an oral, RAS(ON) G12D-selective, tri-complex inhibitor in patients with previously treated KRAS G12D non-small cell lung cancer (NSCLC)
19天前
已完结
Abstract CT019: Preliminary safety and antitumor activity of zoldonrasib (RMC-9805), an oral, RAS(ON) G12D-selective, tri-complex inhibitor in patients with KRAS G12D non-small cell lung cancer (NSCLC) from a phase 1 study in advanced solid tumors
19天前
已完结
Preliminary safety, antitumor activity, and circulating tumor DNA (ctDNA) changes with RMC-9805, an oral, RAS(ON) G12D-selective tri-complex inhibitor in patients with KRAS G12D pancreatic ductal adenocarcinoma (PDAC) from a phase 1 study in advanced solid tumors
19天前
已完结
皖公网安备34019202002308
